Latest recommendation updates
ATAGI have not made any new updates since 9 March 2022.
Recent ATAGI considerations
On Wednesday 16 March 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. As of 14 March 2022, over 55 million doses of COVID-19 vaccines have been administered in Australia.
ATAGI encourages parents of children aged 5-11 to make an appointment for the second dose of COVID-19 vaccine. ATAGI also encourages anyone aged 16 years and over to receive a booster dose as soon as they are eligible.
Upcoming ATAGI considerations
Evidence relating to second COVID-19 booster doses
ATAGI is currently finalising advice to the Minister for Health on the need for a winter dose of COVID-19 vaccine, particularly for older people, who are at a high risk of severe disease.
The development of this advice is based on a thorough review of all the current and emerging evidence on COVID-19 booster doses, including data on effectiveness, waning of immunity, international program settings, national vaccination coverage and operational flexibility where appropriate.
ATAGI will continue to regularly review the data on use of COVID-19 boosters and the epidemiology in Australia during autumn and winter, updating advice to the Government as required.
COVID-19 vaccine safety
The TGA Weekly Report provides a detailed breakdown of adverse events following immunisation.
Resources and recent statements
ATAGI recommends review of the following key resources:
- 2 March 2022: ATAGI updated advice on COVID-19 booster vaccinations
- 28 February 2022: ATAGI Clinical Guidance for COVID-19 vaccine providers
- 18 February 2022: ATAGI guidance on temporary medical exemptions for COVID-19 vaccines.
- 3 February 2022: ATAGI Statement on booster doses for adolescents 16 to 17 years
- 24 January 2022: ATAGI statement on the use of Novavax COVID-19 vaccine.
- 19 January 2022: Updated ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised .